News

The Pharma Letter4h
The week in pharma: action, reaction and insight – week to July 11
The US Food and Drug Administration (FDA) last week authorized KalVista Pharmaceutical’s Ekterly for the treatment of acute ...
The Pharma Letter23h
EURneffy/neffy emerging as serious EpiPen alternative—and the data keeps coming
Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...